Research Article
[Retracted] Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients
Table 3
Univariate and multivariate overall survival analysis of HCC patients by the Cox proportional hazards.
| Variables | Univariate | Multivariate | HR (95%CI) | P | HR (95%CI) | P |
| Age (≥65 vs. <65) | 1.51 (1.08–2.10) | 0.016 | 1.65 (1.18–2.31) | 0.003 | Gender (male vs. female) | 1.01 (0.72–1.41) | 0.967 | | | Grade (G3 vs. G2+G1) | 1.37 (0.97–1.91) | 0.071 | | | Stage (III + IV vs. I + II) | 2.14 (1.51–3.02) | <0.001 | 2.18 (1.54–3.08) | <0.001 | TMB (high vs. low) | 0.99 (0.97–1.00) | 0.055 | | | MUC16 (mutant vs. wild) | 0.65 (0.44–0.94) | 0.022 | 0.64 (0.44–0.93) | 0.018 |
|
|